by H Ali | Dec 10, 2025 | News
BADBIR Participants Using the Patient Portal Your data Participant FAQs Patient Newsletters Clinicians Eligibility Study information Conducting BADBIR remotely Associate Principal Investigator Scheme Centre Report Average daily dose Participating centres Steering...
by H Ali | Nov 28, 2025 | Clinician Newsletters, Newsletters
Welcome to the 2025 update. BADBIR is a world leading pharmacovigilance Register for psoriasis built through the collective effort of the UK and Ireland dermatology community. While we prepare an accessible version of the update available here, you can download a...
by H Ali | Sep 15, 2025 | News
Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, Catherine H Smith, Richard B Warren, Christopher E M Griffiths, BADBIR study group British Journal of Dermatology, ljaf017, https://doi.org/10.1093/bjd/ljaf017 ← Previous Next → Related Recent Posts BADBIR...
by H Ali | Jul 18, 2025 | News
Please be aware that BADBIR cannot accept any new registrations at baseline for patients starting Taltz after 31st July. Participants must have started treatment and provided consent before 1st August to be accepted. If participants signed consent and commenced Taltz...
by H Ali | Jul 18, 2025 | Uncategorised
BADBIR Participants Using the Patient Portal Your data Participant FAQs Patient Newsletters Clinicians Eligibility Study information Conducting BADBIR remotely Associate Principal Investigator Scheme Centre Report Average daily dose Participating centres Steering...
